According to scientists at Cannabis Science Inc., a company which specializes in cannabis research and development for medical purposes, cannabis based drugs could slow the H1N1 ‘swine flu’ pandemic.
Director and Chief Science Officer for CSI Dr. Robert J. Melamede says: “Research into use of whole cannabis extracts and multi-cannabinoid compounds has provided the scientific rationale for medical marijuana's efficacy in treating some of the most troubling diseases mankind now faces, including infectious diseases such as the flu and HIV, autoimmune diseases such as ALS (Lou Gehrig's Disease), multiple sclerosis, arthritis, and diabetes, neurological conditions such as Alzheimer's, stroke and brain injury, as well as numerous forms of cancer.”
Dr Melamede continued, “The high lethality of some strains of flu can be attributed to the excessive inflammatory response driven by Tumor Necrosis Factor (TNF). Endocannabinoids are nature's way of controlling TNF activity. Phytocannabinoids can mimic the natural endocannabinoids to prevent excessive inflammatory immune responses.”
He believes the potential for cannabinoids that naturally prevent excessive inflammatory immune responses is enormous. He stated, "Based upon recent discoveries regarding the role that endocannabinoid system plays in maintaining human health, we may have a unique solution to the looming threat posed by deadly influenza strains that we believe, if implemented, could save millions of lives."
Read the full article here.